Antibody therapy reverses biological signatures of COVID-19 progression.
- DOI
- 10.1016/j.xcrm.2022.100721
- Published
- 2022 Aug 16
- Container
- Cell reports. Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2022.100721,
title = {Antibody therapy reverses biological signatures of COVID-19 progression.},
author = {Maher MC and Soriaga LB and Gupta A and Chen YP and di Iulio J and Ledoux S and Smithey MJ and Cathcart AL and McKusick K and Sun D and Aldinger M and Alexander E and Purcell L and Ding X and Peppercorn A and Austin D and Mogalian E and Yeh WW and Shapiro AE and Corti D and Virgin HW and Pang PS and Telenti A},
year = {2022},
journal = {Cell reports. Medicine},
doi = {10.1016/j.xcrm.2022.100721},
url = {https://doi.org/10.1016/j.xcrm.2022.100721}
}RIS
TY - JOUR TI - Antibody therapy reverses biological signatures of COVID-19 progression. AU - Maher MC AU - Soriaga LB AU - Gupta A AU - Chen YP AU - di Iulio J AU - Ledoux S AU - Smithey MJ AU - Cathcart AL AU - McKusick K AU - Sun D AU - Aldinger M AU - Alexander E AU - Purcell L AU - Ding X AU - Peppercorn A AU - Austin D AU - Mogalian E AU - Yeh WW AU - Shapiro AE AU - Corti D AU - Virgin HW AU - Pang PS AU - Telenti A PY - 2022 JO - Cell reports. Medicine DO - 10.1016/j.xcrm.2022.100721 UR - https://doi.org/10.1016/j.xcrm.2022.100721 ER -
APA
MC, M., LB, S., A, G., YP, C., J, D. I., S, L., MJ, S., AL, C., K, M., D, S., M, A., E, A., L, P., X, D., A, P., D, A., E, M., WW, Y., AE, S., D, C., HW, V., PS, P., & A, T. (2022). Antibody therapy reverses biological signatures of COVID-19 progression.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2022.100721
Source records
- pubmed · retrieved 2026-09-26T08:15:23.993Z